First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Marcello Tiseo; Marco Bartolotti; Francesco Gelsomino; Andrea Ardizzoni

doi:10.1586/era.09.3

First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype

Expert Review of Anticancer Therapy ◽

10.1586/era.09.3 ◽

2009 ◽

Vol 9 (4) ◽

pp. 425-435 ◽

Cited By ~ 19

Author(s):

Marcello Tiseo ◽

Marco Bartolotti ◽

Francesco Gelsomino ◽

Andrea Ardizzoni

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Histologic Subtype ◽

First Line Treatment

Download Full-text

The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer

Expert Opinion on Biological Therapy ◽

10.1080/14712598.2021.1869209 ◽

2020 ◽

pp. 1-7

Author(s):

Danilo Rocco ◽

Luigi Della Gravara ◽

Ciro Battiloro ◽

Cesare Gridelli

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants

Cancer Medicine ◽

10.1002/cam4.2984 ◽

2020 ◽

Vol 9 (10) ◽

pp. 3328-3336 ◽

Cited By ~ 3

Author(s):

Haiyan Xu ◽

Quan Zhang ◽

Li Liang ◽

Junling Li ◽

Zhefeng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer

Translational Cancer Research ◽

10.21037/tcr.2019.12.57 ◽

2019 ◽

Vol 8 (8) ◽

pp. E11-E14

Author(s):

Teppei Yamaguchi ◽

Toyoaki Hida

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1450-6 ◽

2010 ◽

Vol 67 (2) ◽

pp. 475-479 ◽

Cited By ~ 8

Author(s):

Xin-Hua Xu ◽

Jin Su ◽

Xiang-Yang Fu ◽

Feng Xue ◽

Qiao Huang ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Effect ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Cited By ~ 4

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective

PharmacoEconomics - Open ◽

10.1007/s41669-021-00288-1 ◽

2021 ◽

Author(s):

Nan Qiao ◽

Ralph Insinga ◽

Thomas Burke ◽

Gilberto Lopes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Cost Minimization ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Payer Perspective ◽

First Line Treatment

Download Full-text

Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Annals of Oncology ◽

10.1093/annonc/mdy511.005 ◽

2018 ◽

Vol 29 ◽

pp. x40-x41 ◽

Cited By ~ 41

Author(s):

N.A. Rizvi ◽

B. Chul Cho ◽

N. Reinmuth ◽

K.H. Lee ◽

M.-J. Ahn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

First Line Treatment

Download Full-text

Pemetrexed approved for the first-line treatment of non-small-cell lung cancer: summary of the NICE appraisal

The Lancet Oncology ◽

10.1016/s1470-2045(09)70289-x ◽

2009 ◽

Vol 10 (11) ◽

pp. 1031-1032 ◽

Cited By ~ 4

Author(s):

Panagiota Vrouchou ◽

Prashanth Kandaswamy ◽

Elisabeth George ◽

David Barnett

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text